Acquisition of BioNovion Holding B.V. (Tables)

12 Months Ended

Dec. 31, 2016

A summary of the total purchase consideration on October 30, 2015 was as follows (in thousands):

Cash consideration	$	19,006
Fair value of Aduro common stock issued		11,452
Fair value of Contingent Purchase Price		3,775
Total purchase consideration	$	34,233

The following table summarizes the preliminary fair value of assets acquired and liabilities assumed on October 30, 2015 (in thousands):

Assets acquired and liabilities assumed:
Cash and cash equivalents	$	4,684
Accounts receivable		180
Prepaid expenses and other current assets		57
Property and equipment		814
Accounts payable		(1,460	)
Accrued expenses and other liabilities		(780	)
Net tangible assets acquired		3,495
Intangible assets:
License agreement		10,857
In-process research and development		18,827
Goodwill		8,475
Net intangible assets acquired		38,159
Deferred tax liabilities		(7,421	)
Total	$	34,233

	Year Ended December 31,
	2015			2014
	(Unaudited)
Revenue	$	78,272		$	19,944
Net loss		(39,520	)		(19,390	)
Basic and diluted net loss per share		(0.76	)		(24.31	)